BioCentury
ARTICLE | Company News

Genzyme General, Genzyme Molecular deal

January 7, 2002 8:00 AM UTC

GZMO transferred its cancer diagnostics IP to GENZ's Genzyme Genetics business unit. Genzyme Genetics will have rights to cancer markers and cancer-related genes for use in diagnostic development and ...